Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (111-120 of 277) with videos related to

Pageof 28
Sort By:
Blood Cancer Journal|July 1, 2022
B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cellsZhiquan Wang, Huihuang Yan, Justin C Boysen, et al.
Journal of the American Academy of Dermatology|July 19, 2020
Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemiaGeffen Kleinstern, Abdul Rishi, Sara J Achenbach, et al.
Haematologica|June 15, 2019
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single centerYucai Wang, Marcella A Tschautscher, Kari G Rabe, et al.
British Journal of Haematology|May 29, 2019
Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphomaYucai Wang, Matthew J Maurer, Melissa C Larson, et al.
Blood Cancer Journal|May 16, 2023
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy eraCristina Correia, Matthew J Maurer, Samantha J McDonough, et al.
Blood|November 5, 2010
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemiaTait D Shanafelt, Matthew T Drake, Matthew J Maurer, et al.
Oncotarget|January 17, 2019
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapySutapa Sinha, Justin C Boysen, Kari G Chaffee, et al.
American Journal of Hematology|May 10, 2021
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment eraNicholas J Boddicker, Melissa C Larson, Alessia Castellino, et al.
Human Molecular Genetics|March 22, 2021
Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genesRosalie Griffin Waller, Robert J Klein, Joseph Vijai, et al.
American Journal of Hematology|June 22, 2012
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphomaBridget Charbonneau, Matthew J Maurer, Zachary S Fredericksen, et al.
Pageof 28

Showing results (111-120 of 277) with videos related to

Sort By:
Pageof 28
Blood Cancer Journal|July 1, 2022
B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cellsZhiquan Wang, Huihuang Yan, Justin C Boysen, et al.
Journal of the American Academy of Dermatology|July 19, 2020
Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemiaGeffen Kleinstern, Abdul Rishi, Sara J Achenbach, et al.
Haematologica|June 15, 2019
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single centerYucai Wang, Marcella A Tschautscher, Kari G Rabe, et al.
British Journal of Haematology|May 29, 2019
Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphomaYucai Wang, Matthew J Maurer, Melissa C Larson, et al.
Blood Cancer Journal|May 16, 2023
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy eraCristina Correia, Matthew J Maurer, Samantha J McDonough, et al.
Blood|November 5, 2010
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemiaTait D Shanafelt, Matthew T Drake, Matthew J Maurer, et al.
Oncotarget|January 17, 2019
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapySutapa Sinha, Justin C Boysen, Kari G Chaffee, et al.
American Journal of Hematology|May 10, 2021
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment eraNicholas J Boddicker, Melissa C Larson, Alessia Castellino, et al.
Human Molecular Genetics|March 22, 2021
Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genesRosalie Griffin Waller, Robert J Klein, Joseph Vijai, et al.
American Journal of Hematology|June 22, 2012
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphomaBridget Charbonneau, Matthew J Maurer, Zachary S Fredericksen, et al.
Pageof 28